Fulgent Genetics Inc (FLGT) - News Archive

In an exciting development for Fulgent Genetics, Inc. (NASDAQ: FLGT), the company has received CE certification under the European Union s In Vitro Diagnostic Regulation (EU IVDR) 2017/746 for its germline next-generati...

Fulgent Genetics Secures Five-Year Contract with U.S. Department of Veterans Affairs for Genetic Testing Services In a significant move to enhance healthcare services for American veterans, Fulgent Genetics, Inc. (NASDA...

Fulgent Genetics, Inc. (NASDAQ: FLGT), a technology-based company renowned for its established laboratory services and therapeutic development businesses, has announced that it will release its financial results for the...

Fulgent Genetics, a technology-based company known for its laboratory services and therapeutic development business, has recently made significant announcements regarding its financial results and strategic partnerships...

A Strategic Synergy: Fulgent Pharma and Moffitt Cancer Center Join Forces in the Fight Against Cancer In a landmark move poised to dramatically influence the future of cancer treatment, Moffitt Cancer Center and Fulgent...

Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer TherapeuticsTAMPA, Fla. & LOS ANGELES - Moffitt Cancer Center, a renowned cancer treatment and research center, and Fulgent Pharma, a subsidia...